US 7,745,436 B2Granted

Disalt inhibitors of IL-12 production

AssigneeSynta Pharmaceuticals Corp.

InventorsElena Kostik, Lijun Sun

Life of this patent

Estimating the term…

Abstract

This invention relates to disalt nitrogen-heteroaryl inhibitors of IL-12 production, and related methods and pharmaceutical compositions.

Claims6

Dependent claims

A disalt represented by the formula:

wherein each M− is a conjugate base of a Bronsted acid.

Dependencies are inferred from the claim text.

Facts

Application: 11/105,818Filed 13 Apr 2005 · us provisional application
Priority: 13 Apr 2004
Published: US 2005/0282802 A122 Dec 2005
Granted: 29 Jun 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification32 codes

C07D 239/48
Two or more oxygen, sulphur or nitrogen atoms: two nitrogen atoms
A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of…
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
A61P 3/10
For glucose homeostasis: for hyperglycaemia, e.g. antidiabetics

Family

Application60/562,150Us provisional application · filed 13 Apr 2004
US 2005/0282802 A1Pre-grant publication · published 22 Dec 2005
US 7,745,436 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results